Top Markets
Coin of the day
Almirall, S.A. Almirall, S.A.

Almirall, S.A.

ALM
株式のランク #5430
Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery,... Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the United States, its product line targets various dermatological ailments such as actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, and acne, alongside rare skin conditions. Beyond its core dermatology focus, the company also offers solutions for cardiovascular, musculoskeletal, respiratory, and nervous system disorders, as well as products for digestive health, anti-infectives for systemic use, genitourinary conditions and sex hormones, immunostimulants, and systemic hormonal preparations. Its extensive portfolio includes a range of well-known medications, such as Ilumetri, Solaraze, Skilarence, and Klisyri, among others. Almirall fosters strategic partnerships with numerous entities to advance its pipeline, including research institutions like the University of Dundee and commercial partners such as Eli Lilly and Company. Founded in Barcelona, Spain, in 1943, the company adopted its current name, Almirall, S.A., in May 2009, having previously been known as Laboratorios Almirall, S.A.
株価
$12.45
時価総額
$2.71B
変化(1日)
0.00%
変化(1年)
-4.14%
ES
取引 Almirall, S.A. (ALM)

カテゴリー

Almirall, S.A.(ALM)の配当利回りの履歴
Almirall, S.A.(銘柄コード: ALM)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Almirall, S.A.(ALM)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)